-
Monoclonal antibodies specific for simian virus 40 tumor antigens.
J Virol. 1981 Sep;39(3):861-9
PMID: 6169844
-
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
Cell. 1994 Mar 25;76(6):1013-23
PMID: 8137420
-
C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
Proc Natl Acad Sci U S A. 1990 Jan;87(1):6-10
PMID: 1688660
-
Suppression of human colorectal carcinoma cell growth by wild-type p53.
Science. 1990 Aug 24;249(4971):912-5
PMID: 2144057
-
The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
EMBO J. 1990 Oct;9(10):3253-60
PMID: 2145148
-
Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
Oncogene. 1991 Oct;6(10):1791-7
PMID: 1923504
-
Participation of p53 protein in the cellular response to DNA damage.
Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11
PMID: 1933891
-
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
Nature. 1992 Mar 19;356(6366):215-21
PMID: 1552940
-
Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.
J Cell Sci. 1992 Jan;101 ( Pt 1):183-9
PMID: 1569122
-
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
Cell. 1992 Jun 26;69(7):1237-45
PMID: 1535557
-
An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.
J Immunol Methods. 1992 Jul 6;151(1-2):237-44
PMID: 1378473
-
Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
J Cell Biochem. 1992 Jun;49(2):208-15
PMID: 1400626
-
Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9210-4
PMID: 1409626
-
mdm2 expression is induced by wild type p53 activity.
EMBO J. 1993 Feb;12(2):461-8
PMID: 8440237
-
Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence.
Biochem Biophys Res Commun. 1993 Mar 15;191(2):662-8
PMID: 8384849
-
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
Nature. 1993 Apr 29;362(6423):857-60
PMID: 8479525
-
Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences.
Oncogene. 1993 Aug;8(8):2159-66
PMID: 8336941
-
Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
Nature. 1993 Sep 23;365(6444):349-52
PMID: 8377827
-
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.
Genes Dev. 1993 Oct;7(10):1850-61
PMID: 8405995
-
Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F.
EMBO J. 1993 Nov;12(11):4317-24
PMID: 8223441
-
Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein.
J Virol. 1994 Aug;68(8):5027-35
PMID: 8035503
-
DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein.
EMBO J. 1994 Jul 1;13(13):3104-14
PMID: 8039504
-
Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function.
Oncogene. 1994 Sep;9(9):2707-16
PMID: 8058335
-
Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein.
Cell. 1994 Sep 9;78(5):799-811
PMID: 8087847
-
DP and E2F proteins: coordinating transcription with cell cycle progression.
Curr Opin Cell Biol. 1994 Dec;6(6):859-66
PMID: 7880534
-
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2403-7
PMID: 7892279
-
In vivo association of E2F and DP family proteins.
Mol Cell Biol. 1995 May;15(5):2536-46
PMID: 7739537
-
E2F-5, a new E2F family member that interacts with p130 in vivo.
Mol Cell Biol. 1995 Jun;15(6):3082-9
PMID: 7760804
-
Cloning and characterization of human DP2, a novel dimerization partner of E2F.
Oncogene. 1995 Jun 1;10(11):2085-93
PMID: 7784053
-
Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.
Nature. 1995 Jun 22;375(6533):691-4
PMID: 7791903
-
Interaction between the retinoblastoma protein and the oncoprotein MDM2.
Nature. 1995 Jun 22;375(6533):694-8
PMID: 7791904
-
Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?
Cell. 1993 Nov 19;75(4):765-78
PMID: 8242748
-
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Cell. 1993 Nov 19;75(4):805-16
PMID: 8242751
-
WAF1, a potential mediator of p53 tumor suppression.
Cell. 1993 Nov 19;75(4):817-25
PMID: 8242752
-
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
Oncogene. 1993 Dec;8(12):3411-6
PMID: 8247544
-
p21 is a universal inhibitor of cyclin kinases.
Nature. 1993 Dec 16;366(6456):701-4
PMID: 8259214
-
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.
Mol Cell Biol. 1981 Feb;1(2):101-10
PMID: 6100960